PH12019500702A1 - Method for producing a stabilized pharmaceutical composition in the from of an aqueous solution - Google Patents

Method for producing a stabilized pharmaceutical composition in the from of an aqueous solution

Info

Publication number
PH12019500702A1
PH12019500702A1 PH12019500702A PH12019500702A PH12019500702A1 PH 12019500702 A1 PH12019500702 A1 PH 12019500702A1 PH 12019500702 A PH12019500702 A PH 12019500702A PH 12019500702 A PH12019500702 A PH 12019500702A PH 12019500702 A1 PH12019500702 A1 PH 12019500702A1
Authority
PH
Philippines
Prior art keywords
aqueous solution
producing
pharmaceutical composition
composition
tris
Prior art date
Application number
PH12019500702A
Other languages
English (en)
Inventor
Alexey Leonidovich Kovalenko
Andrey Yurievich Petrov
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostyu Nauchno Tekh Farmacevticheskaya Firma Polysan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostyu Nauchno Tekh Farmacevticheskaya Firma Polysan filed Critical Obschestvo S Ogranichennoi Otvetstvennostyu Nauchno Tekh Farmacevticheskaya Firma Polysan
Publication of PH12019500702A1 publication Critical patent/PH12019500702A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH12019500702A 2016-09-29 2019-03-29 Method for producing a stabilized pharmaceutical composition in the from of an aqueous solution PH12019500702A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2016138632A RU2629204C1 (ru) 2016-09-29 2016-09-29 Способ получения стабилизированной фармацевтической композиции в виде водного раствора
PCT/RU2017/000658 WO2018063028A1 (ru) 2016-09-29 2017-09-07 Способ получения стабилизированной фармацевтической композиции в виде водного раствора

Publications (1)

Publication Number Publication Date
PH12019500702A1 true PH12019500702A1 (en) 2019-11-25

Family

ID=59744837

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019500702A PH12019500702A1 (en) 2016-09-29 2019-03-29 Method for producing a stabilized pharmaceutical composition in the from of an aqueous solution

Country Status (14)

Country Link
CN (1) CN110022858B (ru)
AR (1) AR109775A1 (ru)
BR (1) BR112019006167A2 (ru)
CL (1) CL2019000810A1 (ru)
CO (1) CO2019004133A2 (ru)
EA (1) EA029693B1 (ru)
EC (1) ECSP19030392A (ru)
MD (1) MD4774C1 (ru)
MY (1) MY193623A (ru)
PH (1) PH12019500702A1 (ru)
RU (1) RU2629204C1 (ru)
UA (1) UA118387C2 (ru)
UY (1) UY37426A (ru)
WO (1) WO2018063028A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2651047C1 (ru) * 2017-05-04 2018-04-18 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственная композиция цитопротекторного действия и способ ее получения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2059417C1 (ru) * 1992-10-01 1996-05-10 Данилевич Василий Николаевич Способ стерилизации питательных сред
AU1684799A (en) * 1997-12-25 1999-07-19 Ssp Co., Ltd. Water-base liquid preparation
EA001099B1 (ru) * 1999-06-10 2000-10-30 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Инъекционное лекарственое средство "цитофлавин", обладающее цитопротекторным действием
JP2002161047A (ja) * 2000-11-28 2002-06-04 Terumo Corp ヘモグロビン溶液およびヘモグロビン含有リポソーム
RU2238108C1 (ru) * 2003-01-27 2004-10-20 Нестерук Владимир Викторович Способ стерилизации инъекционного раствора натрия хлорида
CN1679615A (zh) * 2005-02-04 2005-10-12 北京阜康仁生物制药科技有限公司 复方小儿能量合剂水溶性维生素制剂及其应用
CN101601647B (zh) * 2009-07-09 2010-09-15 周晓东 一种核黄素磷酸钠组合物注射液及制备方法
RU2536994C1 (ru) * 2013-05-17 2014-12-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Концентрированный кислотный компонент, набор для его получения, концентрированный раствор кислотного компонента для получения гемодиализирующего раствора и способ его получения
WO2015113035A1 (en) * 2014-01-27 2015-07-30 Abbott Laboratories Aseptic filtration process
WO2015126942A1 (en) * 2014-02-18 2015-08-27 Glenn Abrahmsohn Compositions and methods for pain relief without numbness
US10627407B2 (en) * 2015-03-12 2020-04-21 Mars, Incorporated Ultra high resolution mass spectrometry and methods of using the same

Also Published As

Publication number Publication date
MY193623A (en) 2022-10-20
BR112019006167A2 (pt) 2019-06-18
MD4774C1 (ru) 2022-06-30
CO2019004133A2 (es) 2019-09-30
UA118387C2 (uk) 2019-01-10
MD4774B1 (ru) 2021-11-30
MD20190038A2 (ru) 2019-10-31
CN110022858B (zh) 2021-12-14
EA201700072A1 (ru) 2018-03-30
CL2019000810A1 (es) 2019-08-02
RU2629204C1 (ru) 2017-08-25
UY37426A (es) 2018-04-30
AR109775A1 (es) 2019-01-23
WO2018063028A1 (ru) 2018-04-05
CN110022858A (zh) 2019-07-16
EA029693B1 (ru) 2018-04-30
ECSP19030392A (es) 2019-08-30

Similar Documents

Publication Publication Date Title
CY1121782T1 (el) Διαδικασια για ξηρανση της bibw2992, tων αλατων αυτης και στερεων φαρμακευτικων σκευασματων που περιλαμβανουν αυτο το δραστικο συστατικο
CN103704264B (zh) 一种消毒清洁剂
PH12020551692A1 (en) 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors
MX2019011785A (es) Proceso para preparar compuestos de 2,3-dihidrotiazolo[3,2-a]pirim idin-4-io quirales.
EA202192783A1 (ru) Модулятор регулятора трансмембранной проводимости при муковисцидозе, фармацевтические композиции, способы лечения и способ получения указанного модулятора
MY189761A (en) Quinazoline derivatives used to treat hiv
WO2009139576A3 (ko) 신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
FI75492C (fi) Foerfarande foer framstaellning av en steril, injicerbar, fysiologiskt godtagbar loesning av ett roentgenkontrastmedel samt en som utgaongsmaterial anvaend loesning av ett roentgenkontrastmedel och ett fysiologiskt godtagbart buffertsystem.
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
MX2015017512A (es) Compuestos 2,3-dihidrobenzofuran-5-ilicos como inhibidores de cinasas dyrk.
PH12019500394A1 (en) Bicyclic nitrogenated heterocyclic compound
PH12014501711A1 (en) Benzyl sulfonamide derivatives useful as mogat-2 inhibitors
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
PH12019500702A1 (en) Method for producing a stabilized pharmaceutical composition in the from of an aqueous solution
SG11201907472QA (en) Composition for inhibiting myofibrosis
MX2020005564A (es) Sales de 4-amino-n-(1-((3-cloro-2-fluorofnil)amino)-6-metilisoquin olin-5-il)tieno[3,2-d]pirimidino-7-carboxamida, y formas cristalinas de las mismas.
JP2011026350A5 (ru)
MX2018010177A (es) Compuestos de 6,7-dihidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxa mida.
PH12020551154A1 (en) Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid
JOP20210036A1 (ar) مثبطات او- جليكوبروتين-2-أسيتاميدو-2-ديوكسي-3-دي-جلوكوبيرانوسيداز
TH1901001961A (th) วิธีการผลิตส่วนประกอบที่เสถียรทางเภสัชกรรมนำเสนอเป็นวิธีการแก้ปัญหาน้ำ
PH12018501138A1 (en) Pest control composition including iminopyridine derivative
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
ZA202211357B (en) Tablet